VMD

VMD EBITDA Growth

21.82%TTM

Period ending:

VMD TTM EBITDA YoY %%
VMD TTM EBITDA YoY %165.07%-57.66%
2018-06-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

VMD ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 33 observations from Jun 30, 2018 to Jun 30, 2026.

Viemed Healthcare Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
21.8203%
28.055%
17.9121%
9.0612%
11.0399%
7.6036%
14.1885%
23.9396%
38.7837%
54.1315%
52.9845%
37.88%
15.9979%
-2.4841%
-0.866%
-8.786%
-8.3901%
-29.5789%
-36.1088%
-16.6232%
-8.3291%
109.9619%
143.5175%
122.0802%
109.1973%
20.0166%
11.6381%
24.0555%
12.0035%
25.3519%
22.231%
-7.879%
43.745%

Compare ebitda growth

All VMD financial metrics · VMD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.